Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics.
| Market Cap | 4.139 Million | Shares Outstanding | 142.739 Million | Avg 30-day Volume | 26.461 Million |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.54 |
| Price to Revenue | 57.0342 | Debt to Equity | 0.2985 | EBITDA | -58.076 Million |
| Price to Book Value | 2.6539 | Operating Margin | -2511.5257 | Enterprise Value | 92.422 Million |
| Current Ratio | 3.927 | EPS Growth | 0.529 | Quick Ratio | 3.739 |
| 1 Yr BETA | 1.6223 | 52-week High/Low | 6.74 / 0.03 | Profit Margin | -1548.0513 |
| Operating Cash Flow Growth | -60.6077 | Free Cash Flow to Firm (FCFF) TTM | -27.81 Million | Free Cash Flow to Equity (FCFE) TTM | -76.258 Million |
| Altman Z-Score | -0.5709 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
200,000 | 2023-04-10 | 1 | |
|
GUIFFRE CHRISTOPHERD T CFO, COO, TREAS., & ASST. SEC. |
|
0 | 2023-02-15 | 3 |
|
52,380 | 2023-02-15 | 1 | |
|
66,666 | 2023-02-15 | 1 | |
|
71,428 | 2023-02-15 | 1 | |
|
SNOW ELLEN VP, CHIEF ACCOUNTING OFFICER |
|
0 | 2023-02-15 | 3 |
|
52,380 | 2023-02-15 | 1 | |
|
BRENNER ERIN K. CHIEF PRODUCT DEV. OFFICER |
|
0 | 2023-02-15 | 3 |
|
MARICICH YURI CHIEF MEDICAL OFFICER |
|
0 | 2023-02-15 | 3 |
|
MCCANN COREY PRESIDENT AND CEO |
|
0 | 2023-02-15 | 3 |
|
O'BRIEN RONAN CCO, GC, & SECRETARY |
|
0 | 2023-02-15 | 3 |
|
61,904 | 2023-02-15 | 1 | |
|
STRANDBERG JULIA CHIEF COMMERCIAL OFFICER |
|
0 | 2023-02-15 | 3 |
|
52,380 | 2023-02-15 | 1 | |
|
JEFFERY KATHERINE CHIEF PEOPLE OFFICER |
|
8,304 | 2023-01-20 | 2 |
|
12,497,026 | 2022-12-09 | 0 | |
|
TEMASEK HOLDINGS (PRIVATE) LTD |
|
26,803,573 | 2021-12-03 | 0 |
|
18,631,771 | 2021-12-03 | 1 | |
|
21,804,540 | 2021-12-03 | 0 | |
|
10,766,587 | 2021-12-03 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 22:15:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 21:45:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 21:15:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 20:45:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 20:15:07 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 19:45:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 19:15:03 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 18:45:03 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 18:15:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 17:45:03 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 17:15:03 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 16:45:05 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 16:15:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 15:45:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 15:15:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 14:45:04 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 14:15:03 UTC | -2.8131 | 8.1331 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 13:45:03 UTC | -2.7745 | 8.0945 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 13:15:04 UTC | -2.7745 | 8.0945 | 950000 |
| PEAR THERAPEUTICS INC PEARQ | 2023-12-08 12:45:05 UTC | -2.7745 | 8.0945 | 950000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
